{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:00:20Z","timestamp":1791511220370,"version":"4.3.4"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:p>SMARCA4-deficient thoracic sarcoma (SMARCA4-DTS) is a recently described entity with an aggressive clinical course and specific genetic alterations of the BAF chromatin remodeling complex. In the present study, we reviewed the clinical and pathologic features of 30 cases of SMARCA4-DTS, discussed its main differential diagnoses and the challenging diagnostic scenarios that the average pathologist may face. In addition, we tested the specificity of the \u201cSMARCA4-DTS immunohistochemical signature\u201d (co-loss of SMARCA4 and SMARCA2 with overexpression of SOX2) in a large cohort of intrathoracic malignancies. Patients ranged from 28 to 90 years of age (median: 48\u2009y), with a marked male predominance (male:female=9:1) and they were usually smokers. Tumors were generally large compressive masses located in the mediastinum (n=13), pleura (n=5), lung (n=2) or in 2 or more of these topographies (n=10). Treatment strategies were varied, including 1 case treated with EZH2 inhibitors. Median overall survival was 6 months. Histologically, tumors were poorly differentiated frequently showing rhabdoid features. A subset of cases showed a focal myxoid stroma (7%, n=2\/30) and rare cases displayed a previously unreported pattern simulating desmoplastic small round cell tumors (7%, n=2\/30). Making a diagnosis was challenging when dealing with biopsy material from massively necrotic tumors and in this setting the expression of SOX2, CD34, and SALL4 proved useful. All tested cases displayed concomitant loss of SMARCA4 and SMARCA2 and most tumors expressed epithelial markers (Pan-keratin or EMA) (n=29\/30), SOX2 (n=26\/27), and CD34 (n=17\/27). SMARCB1 expression was retained in all cases (23\/23). SALL4 and Claudin-4 were expressed in a subset of cases (n=7\/21 and 2\/19, respectively). TTF-1 and P63 were focally expressed in 1 case each. P40 and NUT were not expressed (0\/23 and 0\/20, respectively) The SMARCA4-DTS immunohistochemical signature was both sensitive and specific, with only a subset of small cell carcinoma of the ovary hypercalcemic type showing overlapping phenotypes. Our study confirms and expands the specific features of SMARCA4-DTS, emphasizing the fact that they can be straightforwardly identified by pathologists.<\/jats:p>","DOI":"10.1097\/pas.0000000000001188","type":"journal-article","created":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T11:29:06Z","timestamp":1542454146000},"page":"455-465","source":"Crossref","is-referenced-by-count":185,"title":["SMARCA4-deficient Thoracic Sarcomas"],"prefix":"10.1097","volume":"43","author":[{"given":"Raul","family":"Perret","sequence":"first","affiliation":[{"name":"Bergonie Institute, Department of Pathology, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Chalabreysse","sequence":"additional","affiliation":[{"name":"Hospices civils de Lyon, Groupement Hospitalier Est, Department of Pathology, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Watson","sequence":"additional","affiliation":[{"name":"Marie Lannelongue Hosital, Department of Pathology, Le Plessis Robinson, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Serre","sequence":"additional","affiliation":[{"name":"University of Grenoble Joseph Fourier"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Garcia","sequence":"additional","affiliation":[{"name":"Claude Bernard University Lyon 1, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Forest","sequence":"additional","affiliation":[{"name":"L\u00e9on B\u00e9rard Center, Department of Oncology, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Yvorel","sequence":"additional","affiliation":[{"name":"L\u00e9on B\u00e9rard Center, Department of Oncology, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pissaloux","sequence":"additional","affiliation":[{"name":"Montpellier University Hospital, Department of Pathology, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Thomas de Montpreville","sequence":"additional","affiliation":[{"name":"Bordeaux University, Talence, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Masliah-planchon","sequence":"additional","affiliation":[{"name":"Curie Institute, g\u00e9n\u00e9tique somatique unit, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lantuejoul","sequence":"additional","affiliation":[{"name":"Montpellier University Hospital, Department of Pathology, Montpellier, France"},{"name":"University of Lyon, Claude Bernard Lyon University 1, CNRS 5286, INSERM U1052, Cancer Research Center of Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Brevet","sequence":"additional","affiliation":[{"name":"Hospices civils de Lyon, Groupement Hospitalier Est, Department of Pathology, Lyon, France"},{"name":"Curie Institute, Department of Medical Oncology, INSERMU830 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[{"name":"Curie Institute, Department of Medical Oncology, INSERMU830 Paris, France"},{"name":"AP-HM, North Hospital, Department of Pathology, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Coindre","sequence":"additional","affiliation":[{"name":"Bergonie Institute, Department of Pathology, Bordeaux, France"},{"name":"Translational Research and Innovation, Centre L\u00e9on B\u00e9rard"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Tirode","sequence":"additional","affiliation":[{"name":"Saint-Etienne University Hospital, Department of Pathology, Saint Etienne, France"},{"name":"Leon Berard Center, Department of Pathology, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Le Loarer","sequence":"additional","affiliation":[{"name":"Bergonie Institute, Department of Pathology, Bordeaux, France"},{"name":"Translational Research and Innovation, Centre L\u00e9on B\u00e9rard"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/ng.3399","article-title":"SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas","volume":"47","author":"Le Loarer","year":"2015","journal-title":"Nat Genet"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pbiomolbio.2010.05.001","article-title":"Structure and function of SWI\/SNF chromatin remodeling complexes and mechanistic implications for transcription","volume":"102","author":"Tang","year":"2010","journal-title":"Prog Biophys Mol Biol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molcel.2006.10.025","article-title":"DNA translocation and loop formation mechanism of chromatin remodeling by SWI\/SNF and RSC","volume":"24","author":"Zhang","year":"2006","journal-title":"Mol Cell"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cell.2009.01.009","article-title":"Understanding the words of chromatin regulation","volume":"136","author":"Wu","year":"2009","journal-title":"Cell"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.critrevonc.2018.01.009","article-title":"The SWI\/SNF complex subunit genes: their functions, variations, and links to risk and survival outcomes in human cancers","volume":"123","author":"Savas","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/modpathol.2017.11","article-title":"Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities","volume":"30","author":"Yoshida","year":"2017","journal-title":"Mod Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/modpathol.2017.61","article-title":"SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior","volume":"30","author":"Sauter","year":"2017","journal-title":"Mod Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.humpath.2017.05.024","article-title":"SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources","volume":"70","author":"Kuwamoto","year":"2017","journal-title":"Hum Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/28212","article-title":"Truncating mutations of hSNF5\/INI1 in aggressive paediatric cancer","volume":"394","author":"Versteege","year":"1998","journal-title":"Nature"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ng.2931","article-title":"Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type","volume":"46","author":"Witkowski","year":"2014","journal-title":"Nat Genet"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/path.4633","article-title":"Dual loss of the SWI\/SNF complex ATPases SMARCA4\/BRG1 and SMARCA2\/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type","volume":"238","author":"Karnezis","year":"2016","journal-title":"J Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.4362","article-title":"No small surprise\u2014small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour","volume":"233","author":"Foulkes","year":"2014","journal-title":"J Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/his.12632","article-title":"Frequent co-inactivation of the SWI\/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours","volume":"67","author":"Rao","year":"2015","journal-title":"Histopathology"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"13796","DOI":"10.1073\/pnas.250492697","article-title":"Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice","volume":"97","author":"Roberts","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.tcb.2009.10.001","article-title":"Polycomb group complexes\u2014many combinations, many functions","volume":"19","author":"Kerppola","year":"2009","journal-title":"Trends Cell Biol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ajmg.c.31410","article-title":"SWI\/SNF chromatin remodeling complexes and cancer","volume":"166C","author":"Biegel","year":"2014","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-012414-040445","article-title":"SWI\/SNF chromatin remodeling and human malignancies","volume":"10","author":"Masliah-Planchon","year":"2015","journal-title":"Annu Rev Pathol"},{"key":"R18-20230922","first-page":"560","article-title":"Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis","volume":"63","author":"Reisman","year":"2003","journal-title":"Cancer Res"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.humpath.2018.04.003","article-title":"Loss of ARID1A expression is associated with poor prognosis in patients with gastric cancer","volume":"78","author":"Zhu","year":"2018","journal-title":"Hum Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.7150\/jca.19109","article-title":"Expression of ARID1B is associated with poor outcomes and predicts the benefit from adjuvant chemotherapy in bladder urothelial carcinoma","volume":"8","author":"Wang","year":"2017","journal-title":"J Cancer"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"54758","DOI":"10.18632\/oncotarget.10181","article-title":"Comprehensive assessment of the expression of the SWI\/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma","volume":"7","author":"Abou-Taleb","year":"2016","journal-title":"Oncotarget"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PAS.0000000000000941","article-title":"Undifferentiated endometrial carcinomas show frequent loss of core switch\/sucrose nonfermentable complex proteins","volume":"42","author":"K\u00f6bel","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2016.156","article-title":"Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas","volume":"29","author":"Coatham","year":"2016","journal-title":"Mod Pathol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00428-016-1977-y","article-title":"Loss of expression of the SWI\/SNF complex is a frequent event in undifferentiated\/dedifferentiated urothelial carcinoma of the urinary tract","volume":"469","author":"Agaimy","year":"2016","journal-title":"Virchows Arch"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/ng.2628","article-title":"Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy","volume":"45","author":"Kadoch","year":"2013","journal-title":"Nat Genet"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/sj.leu.2403061","article-title":"t(5;14)\/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)","volume":"17","author":"Berger","year":"2003","journal-title":"Leukemia"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/s41379-018-0049-z","article-title":"SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma","volume":"31","author":"Kolin","year":"2018","journal-title":"Mod Pathol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/neuonc\/nos285","article-title":"Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells","volume":"15","author":"Alimova","year":"2013","journal-title":"Neuro Oncol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1158\/1535-7163.MCT-16-0678","article-title":"Selective killing of SMARCA2- and SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type cells by inhibition of EZH2: in vitro and in vivo preclinical models","volume":"16","author":"Chan-Penebre","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(18)30145-1","article-title":"Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study","volume":"19","author":"Italiano","year":"2018","journal-title":"Lancet Oncol"},{"key":"R31-20230922","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26218","article-title":"Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program","volume":"64","author":"Kurmasheva","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature14122","article-title":"EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors","volume":"520","author":"Fillmore","year":"2015","journal-title":"Nature"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/modpathol.2016.230","article-title":"Claudin-4 expression distinguishes SWI\/SNF complex-deficient undifferentiated carcinomas from sarcomas","volume":"30","author":"Schaefer","year":"2017","journal-title":"Mod Pathol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/his.13525","article-title":"Frequent loss of claudin-4 expression in dedifferentiated and undifferentiated endometrial carcinomas","volume":"73","author":"Tessier-Cloutier","year":"2018","journal-title":"Histopathology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201904000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:42:15Z","timestamp":1695408135000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201904000-00003"}},"subtitle":["Clinicopathologic Study of 30 Cases With an Emphasis on Their Nosology and Differential Diagnoses"],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001188","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}